A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation

• Gregory D. Ferguson ,

  * E-mail: gferguson66@yahoo.com

  Affiliation Department of Inflammation Research, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Mercedes Delgado,

  Affiliation Department of Chemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Veronique Plantevin-Krenitsky,

  Affiliation Department of Chemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Kristen Jensen-Pergakes,

  Affiliation Department of Tumor Cell Biology, Pfizer Corporation, San Diego, California, United States of America

  ⨯
• R. J. Bates,

  Affiliation Department of Inflammation Research, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Sanaa Torres,

  Affiliation Department of Inflammation Research, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Maria Celeridad,

  Affiliation Department of Inflammation Research, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Heather Brown,

  Affiliation Department of Pharmacology, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Kelven Burnett,

  Affiliation Department of Pharmacology, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Lisa Nadolny,

  Affiliation Department of Chemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Lida Tehrani,

  Affiliation Department of Chemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Garrick Packard,

  Affiliation Department of Chemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Barbra Pagarigan,

  Affiliation Department of Biochemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Jason Haelewyn,

  Affiliation Department of Biochemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Trish Nguyen,

  Affiliation Department of Biochemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Li Xu,

  Affiliation Department of Inflammation Research, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Yang Tang,

  Affiliation Department of Pharmacology, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Matthew Hickman,

  Affiliation Department of Biochemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Frans Baculi,

  Affiliation Department of Biochemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Steven Pierce,

  Affiliation Department of Biochemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Keiji Miyazawa,

  Affiliation Department of Corporate Planning and Strategy, Kissei Pharmaceutical Company, Matsumoto City, Nagano, Japan

  ⨯
• Pilgrim Jackson,

  Affiliation Department of Biochemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Philip Chamberlain,

  Affiliation Department of Biochemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Laurie LeBrun,

  Affiliation Department of Biochemistry, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Weilin Xie,

  Affiliation Department of Inflammation Research, Celgene Corporation, San Diego, California, United States of America

  ⨯
• Brydon Bennett,

  Affiliation Department of Inflammation Research, Celgene Corporation, San Diego, California, United States of America

  ⨯
•  [ ... ],
• Kate Blease

  Affiliation Department of Pharmacology, Celgene Corporation, San Diego, California, United States of America

  ⨯
• [ view all ]
• [ view less ]